GO:0048011 neurotrophin TRK receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048011 describes the signaling cascade triggered when neurotrophins bind Trk family receptor tyrosine kinases (TrkA, TrkB, TrkC), leading to regulation of downstream cellular processes such as transcription.
• The pathway is central to neuronal survival, differentiation, synaptic plasticity, and development, and its dysregulation is implicated in cancer, neurodegeneration, and migraine.
• Key genes include NGF, BDNF, NT-3, NT-4/5, NTRK1, NTRK2, NTRK3, and downstream effectors like RAS, PI3K, PLCG1, and MAPK1/3.
• Trk receptor activation involves dimerization, autophosphorylation, and recruitment of adaptor proteins that initiate RAS/MAPK, PI3K/AKT, and PLCγ signaling.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting causal roles of TRK pathway components in disease.
• The pathway is a therapeutic target in Huntington's disease, gastric cancer, and migraine, with ongoing research into small-molecule modulators and gene editing approaches.
Description
The neurotrophin TRK receptor signaling pathway (GO:0048011) is a fundamental biological process that governs neuronal survival, differentiation, and plasticity. It is initiated when neurotrophins such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) bind to their cognate Trk receptor tyrosine kinases (TrkA, TrkB, TrkC) on the cell surface. This binding triggers receptor dimerization and autophosphorylation, leading to activation of downstream signaling cascades that regulate gene expression and diverse cellular responses. Researchers study this pathway because it is essential for nervous system development and function, and its dysregulation contributes to a wide range of human diseases, including neurodegenerative disorders, cancer, and chronic pain conditions. Understanding the molecular mechanisms of TRK signaling provides insights into potential therapeutic strategies, from small-molecule inhibitors to CRISPR-based gene editing. The pathway is also a paradigm for receptor tyrosine kinase signaling, offering a model to investigate how extracellular cues are converted into transcriptional programs. Its complexity, involving multiple ligands, receptors, and downstream effectors, makes it a rich subject for functional genomics and drug discovery.
neurotrophin TRK receptor signaling pathway At A Glance
| GO ID | GO:0048011 |
|---|---|
| GO term | neurotrophin TRK receptor signaling pathway |
| Ontology | biological_process |
| Synonym | TrkA signaling pathway, TrkB signaling pathway, TrkC signaling pathway, tropomyosin-receptor-kinase signaling |
| Major function | Transduces neurotrophin signals to regulate neuronal survival, differentiation, and plasticity |
| Ligands | NGF, BDNF, NT-3, NT-4/5 |
| Receptors | TrkA (NTRK1), TrkB (NTRK2), TrkC (NTRK3) |
| Downstream pathways | RAS/MAPK, PI3K/AKT, PLCγ |
| Disease relevance | Cancer, neurodegeneration, migraine, Huntington's disease |
What Is GO:0048011?
GO:0048011, neurotrophin TRK receptor signaling pathway, is defined as the series of molecular signals initiated by neurotrophin binding to its receptor on the surface of a target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. In simpler terms, it is the entire communication chain that starts when a neurotrophin molecule docks onto a Trk receptor and culminates in changes within the cell, such as turning genes on or off.
Why Is neurotrophin TRK receptor signaling pathway Important in Cell Biology?
The neurotrophin TRK receptor signaling pathway is critically important because it controls fundamental aspects of neuronal biology, including survival, growth, and synaptic function, and its perturbation is linked to major human diseases. It serves as a key model for understanding receptor tyrosine kinase signaling and offers multiple targets for therapeutic intervention.
• Regulates neuronal survival and apoptosis during development and in adulthood.
• Controls differentiation and maintenance of specific neuronal populations.
• Modulates synaptic plasticity and learning/memory processes.
• Implicated in cancer, where aberrant TRK signaling promotes tumorigenesis.
• Contributes to neurodegenerative diseases such as Huntington's disease.
• Associated with migraine pathophysiology through neurotrophin dysregulation.
• Provides targets for small-molecule inhibitors and gene therapy.
• Essential for pain sensation and nociceptor function.
• Interacts with other signaling pathways, influencing broad cellular outcomes.
• Serves as a paradigm for studying receptor tyrosine kinase mechanisms.
What Happens During neurotrophin TRK receptor signaling pathway?
Neurotrophin Binding and Receptor Dimerization
In simple terms: A neurotrophin molecule binds to a Trk receptor, causing two receptors to pair up.
The pathway begins when a neurotrophin (e.g., NGF, BDNF, NT-3, NT-4/5) binds to the extracellular domain of a Trk receptor (TrkA, TrkB, or TrkC). This binding induces receptor dimerization, bringing the two kinase domains into close proximity. Each neurotrophin has preferred receptors: NGF binds TrkA, BDNF and NT-4/5 bind TrkB, and NT-3 primarily binds TrkC.
Autophosphorylation and Adaptor Recruitment
In simple terms: The paired receptors activate each other by adding phosphate groups, creating docking sites for other proteins.
Dimerization leads to trans-autophosphorylation of specific tyrosine residues in the intracellular kinase domain of the Trk receptors. These phosphotyrosines serve as docking sites for adaptor proteins such as SHC, GRB2, and PLCγ, which are recruited to the receptor complex. This step is critical for propagating the signal downstream.
Activation of RAS/MAPK Cascade
In simple terms: A chain of proteins gets switched on, ultimately sending a signal to the nucleus to change gene activity.
Recruitment of SHC and GRB2 leads to activation of the RAS-MAPK pathway. GRB2 recruits SOS, a guanine nucleotide exchange factor that activates RAS. Active RAS then activates RAF, MEK, and ERK (MAPK1/3), which translocate to the nucleus and regulate transcription factors such as CREB, influencing genes involved in survival and differentiation.
PI3K/AKT Pathway Activation
In simple terms: Another signaling route promotes cell survival by blocking cell death programs.
Trk receptors also activate phosphatidylinositol 3-kinase (PI3K) through adaptor proteins like GAB1 or directly via IRS-1. PI3K generates PIP3, which recruits AKT to the membrane. AKT is then phosphorylated and activated, promoting cell survival by inhibiting pro-apoptotic proteins such as BAD and caspase-9.
PLCγ Signaling and Calcium Release
In simple terms: A third branch triggers calcium signals that affect many cellular processes.
Phospholipase C-gamma (PLCG1) binds to phosphorylated Trk receptors and is activated. PLCγ hydrolyzes PIP2 into IP3 and DAG. IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC). This branch regulates diverse responses including synaptic plasticity and gene expression.
Regulation of Transcription and Cellular Outcomes
In simple terms: The signals reach the nucleus and change which genes are turned on or off, leading to lasting changes in the cell.
The combined activation of ERK, AKT, and PKC leads to phosphorylation and activation of transcription factors such as CREB, ELK1, and NF-κB. These factors drive expression of genes that promote neuronal survival, growth, and plasticity. The pathway also regulates local protein synthesis and cytoskeletal dynamics, contributing to axon guidance and synapse formation.
Key Genes Involved in GO:0048011 neurotrophin TRK receptor signaling pathway
The neurotrophin TRK receptor signaling pathway involves a core set of ligands, receptors, and downstream effectors that are frequently studied in functional genomics and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGF | Neurotrophin ligand for TrkA | Pain, neurodegeneration, cancer |
| BDNF | Neurotrophin ligand for TrkB | Synaptic plasticity, depression, Huntington's |
| NTF3 | Neurotrophin ligand for TrkC | Neuronal development, hearing |
| NTF4 | Neurotrophin ligand for TrkB | Neuronal survival, plasticity |
| NTRK1 | TrkA receptor tyrosine kinase | Cancer, pain, neurodegeneration |
| NTRK2 | TrkB receptor tyrosine kinase | Obesity, mood disorders, cancer |
| NTRK3 | TrkC receptor tyrosine kinase | Cancer, development |
| SHC1 | Adaptor protein linking Trk to RAS/MAPK | Signal transduction research |
| GRB2 | Adaptor protein for RAS activation | Cancer, signaling |
| SOS1 | Guanine nucleotide exchange factor for RAS | Developmental disorders |
| HRAS | Small GTPase activating MAPK pathway | Cancer, developmental syndromes |
| MAPK1 | ERK2, effector kinase regulating transcription | Cancer, neuronal plasticity |
| MAPK3 | ERK1, effector kinase regulating transcription | Cancer, neuronal plasticity |
| PIK3CA | Catalytic subunit of PI3K | Cancer, survival signaling |
| AKT1 | Serine/threonine kinase promoting survival | Cancer, neurodegeneration |
| PLCG1 | Phospholipase C gamma 1 | Signaling, synaptic plasticity |
| CREB1 | Transcription factor mediating gene expression | Memory, survival |
How Is neurotrophin TRK receptor signaling pathway Regulated?
The neurotrophin TRK receptor signaling pathway is tightly regulated at multiple levels. Receptor availability is controlled by endocytosis and degradation, and by the expression of the p75 neurotrophin receptor, which can modulate Trk signaling. Negative feedback mechanisms include dephosphorylation by phosphatases such as SHP-1 and PTEN, and degradation of signaling intermediates. Additionally, cross-talk with other pathways (e.g., mTOR, ISR) can influence outcomes.
neurotrophin TRK receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NTRK1 | Cancer, pain | Knockout or point-mutation cell lines |
| BDNF | Huntington's disease, depression | Knock-in mice or overexpression models |
| NGF | Gastric cancer, migraine | Conditional knockout or overexpression |
| NTRK2 | Obesity, mood disorders | Knockout and knock-in models |
| PLCG1 | Signaling defects, cancer | Point mutation knock-in |
Cancer
Aberrant activation of TRK signaling, often through NTRK gene fusions or overexpression, drives tumorigenesis in various cancers. NGF promotes gastric tumorigenesis through aberrant cholinergic signaling, highlighting the pathway's role in cancer. Targeting TRK receptors with inhibitors has shown promise in clinical trials.
Neurodegenerative Disorders
Defective neurotrophin signaling contributes to neuronal loss in Huntington's disease and other neurodegenerative conditions. Modulating Trk receptor activity is considered a therapeutic strategy to promote neuronal survival. Reduced BDNF-TrkB signaling is implicated in Alzheimer's and Parkinson's diseases.
Migraine and Pain
Neurotrophins, particularly NGF and BDNF, are involved in migraine pathophysiology and chronic pain. Elevated levels of these factors sensitize nociceptors, and targeting the pathway may offer relief. TrkA inhibitors are being explored for pain management.
From neurotrophin TRK receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NTRK1 affect neuronal survival? | NTRK1 knockout cell line or mouse |
| How does a specific point mutation in NTRK2 alter signaling? | Point-mutation knock-in via CRISPR |
| Can overexpression of BDNF rescue neurodegeneration? | BDNF overexpression lentiviral model |
| What is the role of PLCG1 in TRK signaling? | PLCG1 knockout or point mutant |
| Does NGF promote tumorigenesis? | NGF overexpression in gastric cancer cells |
| How does NT-3 affect TrkC signaling? | NTF3 knockout or knock-in |
How to Study the neurotrophin TRK receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Transcriptional responses to neurotrophins |
| Phosphoproteomics | Phosphorylation events | Mapping signaling networks |
| Western blot | Protein levels and phosphorylation | Validation of pathway activation |
| Immunofluorescence | Protein localization and interactions | Receptor trafficking and signaling |
| CRISPR knockout screens | Gene essentiality and modifiers | Identifying pathway regulators |
| Luciferase reporter assays | Transcription factor activity | CREB/ELK1 activation |
| Patch-clamp electrophysiology | Ion channel function | Neuronal excitability changes |
Transcriptomic Analysis
RNA-seq can measure global changes in gene expression following neurotrophin stimulation or Trk receptor knockout. This reveals downstream transcriptional programs regulated by the pathway.
Proteomic Profiling
Mass spectrometry-based phosphoproteomics identifies phosphorylation events and protein-protein interactions in the TRK signaling cascade, providing a system-level view of pathway activation.
Imaging and Live-Cell Assays
Fluorescence microscopy and FRET biosensors can visualize receptor dimerization, internalization, and downstream kinase activity in real time, offering spatial and temporal resolution.
Functional Genomics Screens
CRISPR library screens can identify genes that modulate TRK signaling, uncovering novel regulators and potential drug targets.
How CRISPR Can Be Used to Study GO:0048011 neurotrophin TRK receptor signaling pathway
Knockout
CRISPR knockout of NTRK1, NTRK2, or NTRK3 in cell lines or primary neurons ablates receptor expression, allowing researchers to study loss-of-function phenotypes such as impaired survival or differentiation.
Point Mutation
Introducing specific point mutations (e.g., in the kinase domain of NTRK2) via CRISPR base editing or HDR can dissect the contribution of individual phosphorylation sites to downstream signaling.
Knock-in
Knock-in of tagged receptors (e.g., GFP-NTRK1) enables live-cell imaging and proteomic analysis of receptor complexes. Disease-associated mutations can also be knocked in to model human disorders.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of neurotrophins (e.g., BDNF) or receptors can enhance pathway activity, useful for studying gain-of-function effects in neurodegeneration and cancer.
How EDITGENE Supports neurotrophin TRK receptor signaling pathway Research
Researchers studying neurotrophin TRK receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in neuronal survival, cancer, or other disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for neurotrophin TRK receptor signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AKT1S1 Knockout HEK293 Cell Line | EDJ-KQ613 | Human | 84335 | Details Get a Quote |
| CASP3 Knockout HEK293 Cell Line | EDJ-KQ632 | Human | 836 | Details Get a Quote |
| NGF Knockout HEK293 Cell Line | EDJ-KQ715 | Human | 4803 | Details Get a Quote |
| NTRK1 Knockout HEK293 Cell Line | EDJ-KQ719 | Human | 4914 | Details Get a Quote |
| DDIT4 Knockout HEK293 Cell Line | EDJ-KQ789 | Human | 54541 | Details Get a Quote |
| BCAR1 Knockout HEK293 Cell Line | EDJ-KQ1304 | Human | 9564 | Details Get a Quote |
| DOCK3 Knockout HEK293 Cell Line | EDJ-KQ4468 | Human | 1795 | Details Get a Quote |
| HAP1 Knockout HEK293 Cell Line | EDJ-KQ6426 | Human | 9001 | Details Get a Quote |
| ZFYVE27 Knockout HEK293 Cell Line | EDJ-KQ7631 | Human | 118813 | Details Get a Quote |
| CASP3 Knockout HCT 116 Cell Line | EDJ-KQ18053 | Human | 836 | Details Get a Quote |
| CASP3 Knockout A-549 Cell Line | EDC07646 | Human | 836 | Details Get a Quote |
| CASP3 Knockout HeLa Cell Line | EDJ-KQ19099 | Human | 836 | Details Get a Quote |
| DOCK3 Knockout HCT 116 Cell Line | EDJ-KQ27031 | Human | 1795 | Details Get a Quote |
| ZFYVE27 Knockout HCT 116 Cell Line | EDJ-KQ32979 | Human | 118813 | Details Get a Quote |
| ZFYVE27 Knockout HeLa Cell Line | EDJ-KQ32980 | Human | 118813 | Details Get a Quote |
Displaying Records 1 To 15 Of 41 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About neurotrophin TRK receptor signaling pathway
What is the neurotrophin TRK receptor signaling pathway?
It is the series of molecular signals initiated by neurotrophin binding to Trk receptor tyrosine kinases, leading to regulation of downstream cellular processes such as transcription.
What genes are involved in neurotrophin TRK receptor signaling pathway?
Key genes include NGF, BDNF, NTF3, NTF4, NTRK1, NTRK2, NTRK3, SHC1, GRB2, SOS1, HRAS, MAPK1, MAPK3, PIK3CA, AKT1, PLCG1, and CREB1.
What diseases are associated with neurotrophin TRK receptor signaling pathway?
It is implicated in cancer, neurodegenerative disorders like Huntington's disease, migraine, and chronic pain.
How does neurotrophin binding activate TRK receptors?
Neurotrophin binding induces receptor dimerization and autophosphorylation, creating docking sites for adaptor proteins that activate downstream cascades.
What are the downstream pathways of TRK signaling?
The main downstream pathways are RAS/MAPK, PI3K/AKT, and PLCγ, which regulate transcription, survival, and calcium signaling.
What is the role of TrkA, TrkB, and TrkC?
TrkA binds NGF, TrkB binds BDNF and NT-4/5, and TrkC binds NT-3, mediating distinct neuronal functions.
How can CRISPR be used to study TRK signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes in the pathway.
What is the p75 neurotrophin receptor's role?
p75 can modulate Trk signaling and independently mediate apoptosis and other responses.
Is TRK signaling a therapeutic target?
Yes, it is targeted in cancer, neurodegeneration, and pain, with small-molecule inhibitors and gene therapies under development.
What methods are used to study TRK signaling?
Common methods include RNA-seq, phosphoproteomics, Western blot, immunofluorescence, and CRISPR screens.
Conclusion
The neurotrophin TRK receptor signaling pathway (GO:0048011) is a central regulator of neuronal biology and a key player in multiple human diseases. Its complex signaling network offers numerous targets for therapeutic intervention and research. CRISPR-based models are invaluable for dissecting its mechanisms and validating candidate genes. EDITGENE provides end-to-end services to support such studies, from knockout to library screening.
References
- 1. Huang EJ et al.. 2003. Trk receptors: roles in neuronal signal transduction.. Annu Rev Biochem 72:609-42 PMID: 12676795
- 2. Huang EJ et al.. 2001. Neurotrophins: roles in neuronal development and function.. Annu Rev Neurosci 24:677-736 PMID: 11520916
- 3. Hayakawa Y et al.. 2017. Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling.. Cancer Cell 31(1):21-34 PMID: 27989802
- 4. Roux PP et al.. 2002. Neurotrophin signaling through the p75 neurotrophin receptor.. Prog Neurobiol 67(3):203-33 PMID: 12169297
- 5. Reichardt LF. 2006. Neurotrophin-regulated signalling pathways.. Philos Trans R Soc Lond B Biol Sci 361(1473):1545-64 PMID: 16939974
- 6. Simmons DA et al.. 2017. Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease.. CNS Neurol Disord Drug Targets 16(3):291-302 PMID: 27823570
- 7. Kaplan DR et al.. 1994. Neurotrophin signal transduction by the Trk receptor.. J Neurobiol 25(11):1404-17 PMID: 7852994
- 8. Martins LB et al.. 2017. Neurotrophins and Migraine.. Vitam Horm 104:459-473 PMID: 28215304
